These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30246268)

  • 21. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
    Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
    Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-cultural Diagnostic Validity of the Multilingual Naming Test (MINT) in a Sample of Older Adults.
    Vélez-Uribe I; Rosselli M; Newman D; Gonzalez J; Gonzalez Pineiro Y; Barker WW; Marsiske M; Fiala J; Lang MK; Conniff J; Ahne E; Goytizolo A; Loewenstein DA; Curiel RE; Duara R
    Arch Clin Neuropsychol; 2024 May; 39(4):464-481. PubMed ID: 38123477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.
    Rodríguez-Salgado AM; Llibre-Guerra JJ; Tsoy E; Peñalver-Guia AI; Bringas G; Erlhoff SJ; Kramer JH; Allen IE; Valcour V; Miller BL; Llibre-Rodríguez JJ; Possin KL
    J Alzheimers Dis; 2021; 79(1):85-94. PubMed ID: 33216033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Test Your Memory-Spanish version (TYM-S): a validation study of a self-administered cognitive screening test.
    Muñoz-Neira C; Henríquez Chaparro F; Delgado C; Brown J; Slachevsky A
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):730-40. PubMed ID: 24390843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
    Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    Dodich A; Cerami C; Cappa SF; Marcone A; Golzi V; Zamboni M; Giusti MC; Iannaccone S
    J Alzheimers Dis; 2018; 61(2):761-772. PubMed ID: 29254091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trajectories of cognitive decline in different types of dementia.
    Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
    Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical utility of naturalistic action test in differentiating mild cognitive impairment from early dementia in memory clinic.
    Bruce I; Ntlholang O; Crosby L; Cunningham C; Lawlor B
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):309-15. PubMed ID: 26264127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can cognitive assessment really discriminate early stages of Alzheimer's and behavioural variant frontotemporal dementia at initial clinical presentation?
    Reul S; Lohmann H; Wiendl H; Duning T; Johnen A
    Alzheimers Res Ther; 2017 Aug; 9(1):61. PubMed ID: 28793933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
    Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
    Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DemTect®--effective to asses MCI and dementia--validation study of the Polish language version.
    Wojtyńska R; Szcześniak D
    Aging Ment Health; 2016; 20(5):510-6. PubMed ID: 25811731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a Harmonised, Three-Item Cognitive Screening Instrument for the Survey of Health, Ageing and Retirement in Europe (SHARE-Cog).
    O'Donovan MR; Cornally N; O'Caoimh R
    Int J Environ Res Public Health; 2023 Sep; 20(19):. PubMed ID: 37835139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?
    Andriuta D; Roussel M; Barbay M; Despretz-Wannepain S; Godefroy O;
    J Alzheimers Dis; 2018; 63(2):625-633. PubMed ID: 29689726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Ritter AR; Leger GC; Miller JB; Banks SJ
    Alzheimer Dis Assoc Disord; 2017; 31(3):187-191. PubMed ID: 28005562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.